Target intelligence / Profile preview

Fibronectin leucine-rich transmembrane protein 3 (FLRT3)

Target
FLRT3
Molecular classification
Other (transmembrane protein, cell adhesion molecule), Receptor (functions as a co-receptor in some pathways)
01

Overview

Fibronectin leucine-rich transmembrane protein 3 (FLRT3) is a member of the FLRT family involved in cell adhesion and receptor signaling, with structural similarity to small leucine-rich proteoglycans found in the extracellular matrix[1][2][3][5]. FLRT3 plays key roles during embryonic development and in the adult, notably in the nervous system as a postsynaptic ligand for latrophilin receptors, where it is important for excitatory synapse formation[1][3]. It also modulates intercellular adhesion, neuronal migration, axon guidance (acting as a co-receptor with Robo1 for Netrin-1), and participates in FGF signaling by interacting with FGFR1, regulating tissue morphogenesis such as heart and craniofacial development[1][3]. FLRT3 is expressed in numerous tissues and has been implicated in pathologies including cancer—where it may help tumor cells evade immune detection—and genetic disorders such as high myopia and hypogonadotropic hypogonadism[1][3][5].

Other names
FLRT3Leucine-rich repeat transmembrane protein FLRT3KIAA1469UNQ856/PRO1865Fibronectin-like domain-containing leucine-rich transmembrane protein 3HH21mKIAA14695530600M07RIKC430047I10RIKRGD1566005
02

Biological functions

Cell adhesionCell migrationNeural development (synapse formation, axon guidance)Regulation of excitatory synapse densityModulation of fibroblast growth factor (FGF) signalingVascular development
03

Disease associations

Cancer (roles in tumor immune evasion)High myopiaDevelopmental disorders (e.g., craniofacial and heart morphogenesis)Hypogonadotropic hypogonadism 21 with or without anosmia (genetic association)Kallmann syndrome (genetic association)
04

Safety considerations

Potential implications for neural development and tissue morphogenesis if dysregulatedPossible implications in cancer cell immune evasion and tumor progression

Beyond the preview

Go deeper on Fibronectin leucine-rich transmembrane protein 3 (FLRT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibronectin leucine-rich transmembrane protein 3 (FLRT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call